Gain detailed insights into the trading activity of Congress members for Katapult Holdings on our government trades page. Stay updated on how elected officials are investing in KPLT.

Katapult Holdings - Government Trades

Katapult Holdings

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

sunset-570881

News

KPLT

Katapult Holdings shares are trading higher by 55% during Thursday&#39;s session. The company reported $75.2 million in gross originations for Q4 2024.

Why Katapult Holdings (KPLT) Shares Are Up 63% Today

Wall Street US stocks

Long Ideas

Pre-Market Outlook

Trading Ideas

FAAS

Top 3 Financials Stocks That Could Blast Off This Quarter

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

AFRM

AUUD

BTTX

CCTG

FUTU

FWBI

GIII

HEAR

HGAS

HOOD

IMRX

MDGL

MOMO

NOVA

PANL

PATH

PERF

PIXY

PRST

PUYI

RAYA

RCMT

RGLS

RMBL

SPRB

SPRO

TCON

UNCY

WIMI

WOOF

Shares of  Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Short Ideas

As of Feb. 14, 2024, five stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 5 Financial Stocks That May Crash In Q1

ATLC

BLFY

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.

Top 4 Financial Stocks That May Explode This Quarter

Earnings

Eurozone

Commodities

Global

AULT

HCTI

PRFX

RXRX

TTOO

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday.

The Dow traded up 0.33% to 34,374.56 while the NASDAQ rose 1.21% to 13,926.89. The S&amp;P 500, also rose, gaining, 0.82% to 4,475.79.

Gold Rises Over 1%; Recursion Pharmaceuticals Shares Spike Higher

ABCL

ADIL

ARDS

ARTW

AVRO

AWIN

BANL

BDRX

BNMV

CING

CMPS

CNTA

CRKN

CSTL

CVKD

DADA

DAKT

ELOX

EXAI

FRGE

FRLN

GDTC

GRRR

HLLY

JUPW

LCID

LMNL

LPSN

MULN

NSPR

SFWL

SILK

SOPA

THTX

WLGS

YELL

Gainers


	Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.


Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 1% on Wednesday.

Following the market opening Wednesday, the Dow traded up 0.78% to 34,527.32 while the NASDAQ rose 1.18% to 13,922.99. The S&amp;P 500, also rose, gaining, 0.88% to 4,478.36.

Nasdaq Rises Over 1%; US Inflation Rate Falls In June

AGMH

ALLR

BASE

BTTR

CARM

CJET

COGT

CVGW

FARM

FGEN

GETY

GROV

HLGN

HOTH

HYZN

MOBQ

MOND

NAMS

Nuveen California Dividend Advantage Municipal Fund 2

OMIC

PLAY

RCRT

RLYB

ROKU

SFIX

SMCI

STER

SVRE

UNFI

VTGN

VXRT

WEJO

YEXT

ZLAB

Gainers


	Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns.


Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

AGRI

ALZN

ELBM

NEXI

RNAZ

SWIM

Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

Katapult Holdings Inc

BofA Securities analyst Rafe Jadrosich downgraded D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) and Smith Douglas Homes Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDHC#NYSE">SDHC</a>), citing a tough outlook for homebuilder stocks <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings" rel="noreferrer noopener">as the spring selling season approaches</a>.
Notably, the analyst says that Homebuilder stocks lagged the market in 2024 due to declining demand in the second half of the year, driven by higher mortgage rates.
The analyst anticipates the tough environment for homebuilders will continue through the first half of 2025.
The analyst expects return-on-equity to decline in 2025 for seven out of eight homebuilders, with order growth impacting margins.
The analyst&#8217;s top picks in builders are Toll Brothers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) and NVR, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>). TOL&#8217;s valuation is attractive compared to other builders with similar or lower ROE. NVR is the only builder in the analyst&#8217;s coverage universe that can hold ROE flat in 2025 vs. 2024.
Housing markets in the Northeast, Midwest, and Mid-Atlantic should outperform the Southeast and other regions, while the move-up and luxury segments are set to outperform entry-level markets, adds the analyst.
DHI: The analyst downgraded D.R. Horton from Buy to Neutral and cut the <a target="_blank" href="https://www.benzinga.com/quote/DHI/analyst-ratings" rel="noreferrer noopener">price forecast from $160 to $150</a>.
The analyst writes that lot costs, which make up 26%-27% of total costs, are rising (+3% QoQ, +10% YoY in first-quarter), and DHI expects similar inflation before moderating to mid-to-high single digits on year in the next couple of quarters.
Due to the tough housing macro (higher rates, more supply), DHI may struggle to raise prices to offset lot cost inflation, adds the analyst.
The analyst says that DHI is no longer investing in its rental segment, but rental inventory already accounts for 11% of book value.
Jadrosich expects a low single-digit ROE for rentals in 2025, which will drag overall ROE by &gt;100bps.
Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43095811/d-r-horton-q1-earnings-beat-despite-soft-housing-market-fy25-outlook-reiterated" rel="noreferrer noopener">D.R. Horton Q1: Earnings Beat Despite Soft Housing Market, FY25 Outlook Reiterated</a>
SDHC: The analyst downgraded the company from Neutral to Underperform and cut the <a target="_blank" href="https://www.benzinga.com/quote/sdhc/analyst-ratings" rel="noreferrer noopener">price forecast from $33 to $22</a>.
Jadrosich says that, like other builders, SDHC faces cost inflation headwinds while higher mortgage rates pressure net prices.
While ~15% community count growth and faster build cycles provide delivery tailwinds, the analyst notes absorptions will also need to improve to meet the guidance.
The valuation appears less compelling compared to peers, given the expectation that Smith Douglas&#8217; delivery growth will moderate in 2025 and its ROE will normalize closer to the group average, adds the analyst.
The analyst expect delivery growth of around 4% in 2025 vs. preliminary guidance of roughly 11% at the mid-point.
Jadrosich expects Smith Douglas to enter 2025 with a backlog that is down roughly 13% YoY.
Price Action: DHI shares are up 2.64% at $146.69, while SDHC sharesa re down 0.37% at $24.22 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43120493/dow-jumps-over-500-points-as-trump-takes-office-investor-sentiment-improves-but-greed-index-remains-in-fear-zone" target="_blank" rel="noreferrer noopener">Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

Large Cap

Downgrades

Price Target

Analyst Ratings

General

SDHC

Homebuilders Brace For Tough 2025, Analyst Downgrades D.R. Horton And Smith Douglas Amid Market Pressures

NVDA

Nvidia Spokesperson Says DeepSeek's Work Shows How New Models Can Be Created, Leveraging Widely-Available Models And Compute That Is Fully Export Control Compliant

Toshi (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TOSHI</a>), a meme coin named after Coinbase co-founder Brian Armstrong, has outperformed meme coin heavyweights like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) over the past week, seeing stellar gains after being <a href="https://www.benzinga.com/quote/COIN">listed on Coinbase</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Toshi (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TOSHI</a>)</td>
<td>&nbsp;$0.00117</td>
<td>$477.8 million</td>
<td>-31.7%&nbsp;</td>
<td>&nbsp;+224.1%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.319&nbsp;</td>
<td>$47 billion</td>
<td>-10%&nbsp;</td>
<td>-12.3%&nbsp;</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001819</td>
<td>$10.7 billion</td>
<td>-8.8%&nbsp;</td>
<td>-11.7%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader BasedTricky emphasized Toshi's strong performance despite market dips, pointing to its impressive $1 billion 24-hour trading volume. 
He <a href="https://x.com/BasedTricky/status/1883873858815463918">predicts</a> that Toshi, dubbed the &#8220;Face of Coinbase,&#8221; could experience a strong rebound as market conditions stabilize.
Another crypto trader, Pennski Hardaway, believes Toshi could redefine the meme coin landscape, especially within Ethereum Virtual Machine (EVM) chains, if it crosses the $1 billion market cap. 
He <a href="https://x.com/0x_Imperius/status/1882588299010908500">sees</a> Toshi as a transformative force that could reignite innovation and enthusiasm in the space, while strengthening Coinbase's position in the crypto industry.
Statistics: Crypto trader rb3k <a href="https://x.com/rbthreek/status/1883333311952777514">noted</a> that the meme coin Toshi occupied the top spot in volume trading on Jan. 26, even outperforming Bitcoin in terms of trading volume.
Over the past seven days, Toshi has accumulated 220% gains leaving behind meme coin leaders like Dogecoin, Shiba Inu and Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>).
Community News: On Jan. 23, Coinbase officially announced Toshi's listing, propelling the token to an all-time high of $0.002273.
However, after a weekend rally, the coin faced a 32% decline in a single day, highlighting its volatility amid broader market uncertainty.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43105356/meme-coin-supercycle-dogecoin-trump-bonk-futures-etf-applications-filed">Meme Coin Supercycle? Dogecoin, Trump, Bonk Futures ETF Applications Filed</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

$TOSHI

Coinbase's Toshi Cat Coin Leaps Past Dogecoin, Shiba Inu With 200% Surge In One Week

BofA Securities analyst downgraded the shares of Bloomin&#8217; Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) from Neutral to Underperform and <a target="_blank" href="https://www.benzinga.com/quote/BLMN/analyst-ratings" rel="noreferrer noopener">lowered the price forecast from $18.00 to $13.00.</a>
Over the last decade, Bloomin&#8217;s transaction growth has averaged a decline of approximately 2% per year across its brands, with its largest brand, Outback, seeing a -1.1% compound annual growth rate (CAGR) in traffic, said the analyst.
Outback US accounted for about 51% of Bloomin&#8217;s (BLMN) revenue in FY24, and following the Brazil licensing, this is expected to rise to around 53%.
Also Read: <a href="https://www.benzinga.com//node/43241652">Starbucks Q1 Earnings Preview: Data Shows Visits Down, Will Company Continue Streak Of Missing Revenue Estimates?</a>
While the casual dining sector generally experiences slow growth, Bloomin&#8217;s challenges have allowed competitors to gain a larger market share. The new management&#8217;s primary focus is on reversing the decline in traffic, noted the analyst.
Although BLMN&#8217;s volumes have consistently decreased, its margins have remained unexpectedly strong. Domestic same-store transaction counts across the BLMN system are roughly 10% lower than in 2019, but restaurant margins have only dropped by 70 basis points.
With flow-through margins around 40% on additional transactions, the analyst would have anticipated a margin decline closer to 260 basis points compared to 2019.
The fact that their pricing has been on par with or higher than direct competitors such as Texas Roadhouse Inc in the steak category, supports this perspective.
While turnarounds in casual dining are uncommon, they are not unattainable, as demonstrated by Chili&#8217;s. However, its parent company, Brinker International Inc made substantial investments in labor to enhance service and marketing efforts to attract customers.
To balance this, Brinker implemented significant price hikes. In contrast, the analyst notes an important difference between Chili&#8217;s and Bloomin&#8217; is that Chili&#8217;s had historically underpriced its competitors.
Bloomin&#8217;s brands, on the other hand, have maintained competitive pricing and lack the scale advantages within their segments to outspend rivals on marketing or value without compromising margins.
Although BLMN is currently priced below its historical average, the analyst anticipates that both revenue and earnings projections will continue to face pressure in the near future.
Price Action: BLMN shares are trading lower by 0.36% at $12.27 at the last check Monday.
Photo via Shutterstock.

BLMN

TXRH

Bloomin' Brands Faces Near-Term Pressure, Analyst Highlights Peer Brinker's Turnaround Roadmap

Ahead of their earnings release, BofA Securities analyst Lawson Winder upgraded Kinross Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) and downgraded Barrick Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>).
Talking about market, the analyst says that Gold opened at $2,706/oz last week, rising to $2,746/oz on January 21, 2025, as the U.S. Dollar weakened.
It closed the week at $2,771/oz, up 2.5%, on President Trump&#8217;s remarks on a less aggressive tariff approach to China.
KGC: The analyst double-upgraded Kinross from Underperform to Buy and raised the price <a target="_blank" href="https://www.benzinga.com/quote/kgc/analyst-ratings" rel="noreferrer noopener">forecast from $9.25 to $12.75</a>.
The analyst notes several concerns surrounding Kinross, such as shorter mine life, maintaining 2 million gold equivalent ounces (GEOs) of annual production, and unit costs, are being addressed.
Consequently, the analyst raised the 2026 GEO production forecast from 1.8 million to 2 million GEO and increased earnings per share (EPS) estimates from $0.64 to $0.78 for 2026.
Despite market concerns about potential corporate acquisitions, Kinross remains disciplined in this regard, adds the analyst.
Additionally, Winder sees potential for Kinross to boost capital returns in 2025 through a share buyback. Overall, the analyst says that the company is well-positioned for fourth-quarter results with potential catalysts in 2025.
GOLD: The analyst downgraded the stock from Buy to Neutral and cut the <a target="_blank" href="https://www.benzinga.com/quote/gold/analyst-ratings" rel="noreferrer noopener">price forecast from $21 to $18</a>.
The analyst writes that as approaching fourth-quarter results, risks are rising, particularly regarding the shutdown of the Loulo-Gounkoto mine in Mali, and the struggling ramp-up of the Pueblo Viejo mine in the Dominican Republic.
In their 2025 model, Winder removed any production from the Loulo-Gounkoto mine due to its suspension amid a tax dispute with the Malian military government.
The analyst says that he sees two possible outcomes: the first, a less favorable tax and royalty agreement allowing continued operation; the second, a complete loss of operations if the government seizes control.
The analyst assumes the mine to restart in late 2025, ramping up to full production in 2026, but under less favorable terms for Barrick Gold.
Consequently, the analyst lowered 2025 estimates for EPS to $1.55 from $1.91 and 2026 EPS to $1.81 from $1.92.
Both Kinross and Barrick Gold will release their fourth-quarter results on <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">Wednesday, February 12, 2025</a>.
Price Action: KGC shares are down 0.89% at $10.60, while GOLD shares are down 1.18% at $15.94 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/01/43093586/barrick-looks-into-portfolio-optimization-sees-pakistan-as-the-new-frontier" target="_blank" rel="noreferrer noopener">Barrick Looks Into Portfolio Optimization, Sees Pakistan As &#8216;The New Frontier&#8217;</a></li>
</ul>
Image via Shutterstock.

Upgrades

GOLD

Kinross Gold's Production Outlook Improves, Analyst Double Upgrades Stock

On Monday, Allakos Inc (NASDAQ:&nbsp;ALLK) revealed topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41280699/allakos-announces-phase-1-trial-results-of-subcutaneous-ak006-in-healthy-volunteers" rel="noreferrer noopener">(CSU), a skin disorder</a>.
&#8220;While AK006 was well tolerated, we are disappointed that the preclinical inhibitory effects observed did not translate to clinical benefit in patients with CSU. As a result, the company has decided to discontinue further clinical development of AK006,&#8221; said Chin Lee, Chief Medical Officer of Allakos.
In the CSU cohort, 34 adult patients refractory to antihistamines with or without prior exposure to omalizumab were enrolled and randomized 2:1 to receive 720 mg of intravenous AK006 (n=23) or placebo (n=11) once every four weeks (Q4W).
AK006 was well-tolerated with a favorable safety profile. There were no serious adverse events (SAEs) in subjects on AK006.
The company plans to discontinue AK006-related activities across clinical, manufacturing, research, and administrative functions and reduce its workforce by approximately 75%.
The company plans to retain approximately 15 employees to explore strategic alternatives, maintain compliance with regulatory and financial reporting requirements, and wind down the phase 1 clinical trial.
In October, &nbsp;Allakos released results from the Phase 1 study of subcutaneous AK006 in healthy volunteers. Subcutaneously administered AK006 showed approximately 77% bioavailability and prolonged receptor occupancy on mast cells and was well-tolerated with a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41280699/allakos-announces-phase-1-trial-results-of-subcutaneous-ak006-in-healthy-volunteers" rel="noreferrer noopener">favorable safety profile</a>.
Allakos ended the fourth quarter of 2024 with approximately $81 million in cash, cash equivalents, and investments. The company estimates that cash used in restructuring activities to close out AK006 development, including severance and contractual payments to vendors, will be approximately $34 million to $38 million.
The company also estimates that most of these restructuring costs will be paid over the first and second quarters of 2025.
Allakos estimates that as of June 30, 2025, it will have cash, cash equivalents, and investments of approximately $35 million to $40 million.
Price Action: ALLK stock is down 78.5% at $0.26 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43237896/vci-global-expands-ai-infrastructure-with-25m-investment" target="_blank" rel="noreferrer noopener">VCI Global Expands AI Infrastructure With $25M Investment</a></li>
</ul>

Biotech

Health Care

ALLK

Why Is Allakos Stock Plunging On Monday?

Across the recent three months, 7 analysts have shared their insights on Bloomin Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.43, a high estimate of $19.00, and a low estimate of $13.00. Observing a downward trend, the current average is 22.71% lower than the prior average price target of $18.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004457_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Bloomin Brands by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$13.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Sell</td>
<td>$13.00</td>
<td>-</td>
</tr>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Brian Mullan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Bloomin Brands. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Bloomin Brands compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Bloomin Brands's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BLMN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bloomin Brands analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Bloomin Brands</h2>
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
<h3>Bloomin Brands's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Bloomin Brands faced challenges, resulting in a decline of approximately -3.8% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Bloomin Brands's net margin excels beyond industry benchmarks, reaching 0.67%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Bloomin Brands's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.61%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Bloomin Brands's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.2%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 9.93, Bloomin Brands adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bloomin Brands Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Throughout the last three months, 4 analysts have evaluated Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $11.38, with a high estimate of $13.00 and a low estimate of $9.50. Marking an increase of 13.8%, the current average surpasses the previous average price target of $10.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004450_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Nexxen International among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Matthew Swanson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$9.50</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$9.50</td>
<td>$8.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Nexxen International. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Nexxen International compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Nexxen International's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Nexxen International's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/NEXN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Nexxen International analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Nexxen International</h2>
Nexxen International Ltd empowers advertisers, agencies, publishers, and broadcasters to utilize video and connected TV. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with advanced and exclusive data at its core.
<h3>A Deep Dive into Nexxen International's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Nexxen International displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 1.81%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: Nexxen International's net margin is impressive, surpassing industry averages. With a net margin of 16.12%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Nexxen International's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.78%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.81%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.07.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NEXN

4 Analysts Assess Nexxen International: What You Need To Know

Ratings for Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $67.0, a high estimate of $69.00, and a low estimate of $65.00. This current average has decreased by 0.74% from the previous average price target of $67.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004441_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Ventas by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$69.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Vikram Malhorta</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$68.00</td>
<td>$71.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ventas. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ventas compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Ventas's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Ventas's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VTR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ventas analyst ratings.</a>
<h2>All You Need to Know About Ventas</h2>
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
<h3>Financial Insights: Ventas</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Ventas displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 7.52%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Ventas's net margin excels beyond industry benchmarks, reaching 1.56%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ventas's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.2%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Ventas's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.08% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Ventas's debt-to-equity ratio is below the industry average at 1.42, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss Ventas Stock

Across the recent three months, 5 analysts have shared their insights on CenterPoint Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CenterPoint Energy, revealing an average target of $33.5, a high estimate of $37.00, and a low estimate of $30.00. Surpassing the previous average price target of $30.50, the current average has increased by 9.84%.
<img src="https://www.benzinga.com/files/images/story/2025/1738004430_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of CenterPoint Energy among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$30.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Paul Fremont</td>
<td>Ladenburg Thalmann</td>
<td>Announces</td>
<td>Buy</td>
<td>$34.50</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$35.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>William Appicelli</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>David Arcaro</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$31.00</td>
<td>$32.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CenterPoint Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of CenterPoint Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for CenterPoint Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of CenterPoint Energy's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CNP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CenterPoint Energy analyst ratings.</a>
<h2>Unveiling the Story Behind CenterPoint Energy</h2>
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.
<h3>CenterPoint Energy: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, CenterPoint Energy faced challenges, resulting in a decline of approximately -0.22% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Utilities sector.
Net Margin: CenterPoint Energy's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.4%, the company may face hurdles in effective cost management.
Return on Equity (ROE): CenterPoint Energy's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.85%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CenterPoint Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.46%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.89.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 5 Analyst Projections For CenterPoint Energy

Rambus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NYSE">RMBS</a>) short percent of float has fallen 11.91% since its last report. The company recently reported that it has 2.81 million shares sold short, which is 3.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Rambus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738004423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Rambus has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Rambus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Rambus's peer group average for short interest as a percentage of float is 9.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

RMBS

(RMBS) - Analyzing Rambus's Short Interest

Government Trades

Katapult Holdings Inc

top performing KPLT trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga